HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers.

AbstractBACKGROUND:
Fractional exhaled nitric oxide (FeNO) is a surrogate marker for airway inflammation, supporting the diagnostic pathway and treatment decisions for asthma patients.
OBJECTIVES:
Aim of this study was to compare the new analyser Vivatmo pro (Bosch, BV) with NIOX VERO (Circassia, CN) and CLD (Ecomedics, EC).
METHODS:
In 100 asthmatics (median 53 years [range 20-87], 62% female, 86% on inhaled corticosteroids [mean 1,300 μg beclomethasone dipropionate or equivalent], 35% treated with biologics) 2 FeNO measurements per device were performed. Additionally, the success rate to achieve a valid NO value was evaluated.
RESULTS:
Sixty-eight percent of the patients had FeNO values below 50 ppb. Median NO concentrations were 31 ppb (range 6-194) for BV, 33 ppb (9-164) for CN and 31ppb (7-353) for EC. Bland-Altman plots suggested an agreement within the predefined limits of ±5 ppb for all analysers within the therapeutically relevant range (0-70 ppb). The highest agreement in FeNO levels were between BV and EC with mean differences of -0.26 (95% CI -1.48 to 0.95) vs. 1.52 (95% CI 0.4-2.6) ppb for CN and EC. The results indicate an equivalence of the methods (two-one sided t test-equivalence test: p < 0.0001, ±5 ppb margins). Acceptance of the measurements was high for all devices (97%). The highest success rate to obtain 2 valid NO values without failed attempts was achieved with the BV analyser (73 vs. 62% for the CN analyser and 46% for the EC analyser).
CONCLUSIONS:
For the range between 0 and 70 ppb, FeNO concentrations measured with all 3 devices were statistically equivalent within predefined acceptance criteria and did not differ in a clinically relevant way.
AuthorsStephanie Korn, Maike Wilk, Stefanie Voigt, Stephan Weber, Thomas Keller, Roland Buhl
JournalRespiration; international review of thoracic diseases (Respiration) Vol. 99 Issue 1 Pg. 1-8 ( 2020) ISSN: 1423-0356 [Electronic] Switzerland
PMID31288246 (Publication Type: Comparative Study, Journal Article)
CopyrightThe Author(s). Published by S. Karger AG, Basel.
Chemical References
  • Anti-Asthmatic Agents
  • Nitric Oxide
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Asthmatic Agents (therapeutic use)
  • Asthma (drug therapy, metabolism, physiopathology)
  • Breath Tests (instrumentation)
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Middle Aged
  • Nitric Oxide (analysis)
  • Vital Capacity
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: